Capricor Therapeutics Inc (CAPR)

[ByMorStock]

CAPR and Cardiac Problems with COVID

READ THIS
https://www.sciencedirect.com/science/article/pii/S0049384821000141

NOW READ THIS
https://www.globenewswire.com/news-release/2020/12/29/2151303/0/en/Capricor-Therapeutics-Announces-DSMB-Recommendation-to-Continue-Phase-II-INSPIRE-Trial-for-Severe-COVID-19-Patients.html

"Dr. Marbán continued, “Based on data from the initial emergency use cases, we are encouraged by the potential of our cell-based therapy, CAP-1002, for treating COVID-19. Many patients are now suffering from COVID-19’s long-term cardiac consequences. As CAP-1002 directly targets cardiac dysfunction, it has the potential to serve as an important tool in treating the virus’s cardiac complications – an unmet medical need in today’s patient population. We are now actively enrolling subjects in Texas and California where case levels continue to rise. We expect to have data available in the first half of 2021 and will continue to evaluate potential partnering opportunities for this program.”

Post this everywhere